Monterey Bio Acquisition Corporation
MTRY · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $53,442 | $52,268 | $51,387 | $143,269 |
| - Cash | $540 | $218 | $146 | $544 |
| + Debt | $1,920 | $1,143 | $0 | $0 |
| Enterprise Value | $54,822 | $53,193 | $51,241 | $142,725 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$339 | -$2,039 | -$864 |
| % Margin | – | – | – | – |
| EBITDA | -$366 | -$339 | -$463 | -$864 |
| % Margin | – | – | – | – |
| Net Income | -$151 | -$152 | -$307 | -$420 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.031 | -0.031 | -0.063 | -0.03 |
| % Growth | 0.3% | 50.4% | -111.1% | – |
| Operating Cash Flow | -$340 | -$133 | -$387 | -$121 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$340 | -$133 | -$387 | -$121 |